# Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV

> **NCT05085145** · PHASE4 · UNKNOWN · sponsor: **Beijing 302 Hospital** · enrollment: 200 (estimated)

## Conditions studied

- People Living With HIV
- COVID-19
- Vaccine

## Interventions

- **BIOLOGICAL:** Coronavirus vaccine

## Key facts

- **NCT ID:** NCT05085145
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05085145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05085145, "Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05085145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*